Gene · 8913
Papers1,769
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,769
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Diterpenoid alkaloids from Delphinium aemulans Nevski and their analgesic and ion channel inhibitory activities. | Phytochemistry | 2027 | 42710726 | PubTator, text mining | PubMed |
| Ginsenoside Rg2 inhibits the cell viability of cisplatin-resistant epithelial ovarian cancer by suppressing CACNA1G-mediated calcium signaling. | Toxicol Appl Pharmacol | 2026 | 42727823 | PubTator, text mining | PubMed |
| Ion-Channel Activity of Characteristic Alkaloids From Uncaria rhynchophylla. | Chem Biodivers | 2026 | 42720106 | PubTator, text mining | PubMed |
| The expanding role of Cav3 channels in glioblastoma. | Trends Pharmacol Sci | 2026 | 42697770 | PubTator, text mining | PubMed |
| Comparative transcriptomics analysis of histone deacetylases, transcription factors, and ion channel genes in human iPSC-cardiomyocytes vs. the adult human heart. | J Precis Med (Amst) | 2026 | 42644057 | PubTator, text mining | PubMed |
| A novel de novo CACNA1G variant p.(Arg1553Gln) associated with neurodevelopmental delay and cerebellar hypoplasia: Expanding the phenotypic spectrum. | Eur J Med Genet | 2026 | 42309484 | PubTator, text mining | PubMed |
| Molecular Pharmacology of T-Type Calcium Channels and Their Roles in Neurological Disorders. | Med Res Rev | 2026 | 42272247 | PubTator, text mining | PubMed |
| Endurance exercise remodels pulmonary vein sleeve myocytes and promotes a proarrhythmic atrial substrate. | Eur Heart J | 2026 | 42178147 | PubTator, text mining | PubMed |
| The four voltage-sensing domains of T-type calcium channels activate near the resting membrane potential. | Nat Commun | 2026 | 42143043 | PubTator, text mining | PubMed |
| Novel Truncating Variant c.1222DupC in RBM20 Causes Cardiomyopathy Consistent With Haploinsufficiency. | Circ Genom Precis Med | 2026 | 42059065 | PubTator, text mining | PubMed |
| L-type calcium channel-mediated lipid metabolic reprogramming in gastric adenocarcinoma progression. | Transl Oncol | 2026 | 41861661 | PubTator, text mining | PubMed |
| Harnessing Piezoelectric Biomaterials for Pathogenic Eradication and Tissue Regeneration. | Exploration (Beijing) | 2026 | 41810067 | PubTator, text mining | PubMed |
| Advances in calcium signalling research for the diagnosis and treatment of depression. | Ann Med | 2026 | 41787814 | PubTator, text mining | PubMed |
| Enhancing KLF15 activity in cardiomyocytes: a novel approach to prevent pathological reprogramming and fibrosis via nuclease-deficient dCas9VPR. | Signal Transduct Target Ther | 2026 | 41771837 | PubTator, text mining | PubMed |
| Implication of the thalamus in sleep alterations observed in Alzheimer's disease. | Alzheimers Dement | 2026 | 41771796 | PubTator, text mining | PubMed |
| Distinct molecular pathways leading to dosage-dependent temozolomide resistance in GBM stem cells. | Cancer Cell Int | 2026 | 41736030 | PubTator, text mining | PubMed |
A multi-omics study on monozygotic twins discordant for amyotrophic lateral sclerosis and literature review underline a potential role for innate immunity and epigenetic dysregulation in disease mechanisms. | Neurol Sci | 2026 | 41639347 | PubTator, text mining | PubMed |
| A case-based explainable graph neural network framework for mechanistic drug repositioning. | Bioinformatics | 2026 | 41533699 | PubTator, text mining | PubMed |
| Transcriptional and epigenetic changes associated with lead exposure in spermatozoa. | Asian J Androl | 2026 | 41527937 | PubTator, text mining | PubMed |
| Genetic Variation Analysis of Essential Tremor: Insights from the China Essential Tremor Alliance Cohort. | Mov Disord | 2026 | 41178571 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8913/papers